IV Equipment Market Projected to Reach $23.92 Billion by 2031
Growth of the IV Equipment Market: Projections to 2031
The IV Equipment Market is poised for remarkable growth, anticipated to rise from approximately $17.82 billion in 2026 to $23.92 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.1%. This surge is influenced by several pivotal factors, primarily the increasing occurrence of chronic illnesses such as diabetes, cancer, and heart diseases, which necessitate regular medical treatment and intravenous therapies.
Key Factors Driving Growth
The demand for intravenous (IV) treatment is significantly driven by the global aging population. Older adults typically require more medical care, including surgeries and the intravenous administration of medications or nutrients. Furthermore, the expanding healthcare infrastructure in emerging economies—and improved access to medical facilities—has opened up new markets for IV equipment.
Technological advancements are transforming the industry as well. The emergence of safer, more efficient IV devices that are user-friendly is promoting their adoption within healthcare settings, thereby contributing to consistent growth in this sector. According to market data, the segment of IV catheters represented a substantial 37.0% of the market share in 2025, with medication administration accounting for a dominant 54.9%.
Segment Insights
Looking ahead, the needle-free connectors and extension sets segment is expected to experience the highest growth rate in the upcoming years, driven by their safety and convenience. Additionally, home care settings are projected to register the fastest CAGR at 7.4%, reflecting a fundamental shift toward outpatient care and home-based treatment options.
Regional Analysis
Regionally, North America is projected to maintain the largest market share, supported by high healthcare expenditures aimed at enhancing medical technologies and catering to the needs of an aging populace. In contrast, the Asia-Pacific region is emerging as the fastest-growing market at a CAGR of 6.5%, due primarily to significant improvements in healthcare facilities and heightened investments in medical services.
Market Applications
The utilization of IV equipment is essential for several applications, with medication administration being particularly critical. This method allows for direct drug delivery into the bloodstream, which is vital for timely and effective treatment in critical care and oncology settings where precise drug delivery is paramount.
Key Players in the Market
Prominent companies leading the IV equipment sector include Becton, Dickinson and Company, B. Braun SE, and Fresenius SE & Co. KGaA, among others. These organizations are significantly investing in innovation and expanding their product lines to capture evolving market demands.
As the industry gears up for these transitions, the IV equipment market stands at a pivotal juncture, with innovations and shifts toward home healthcare promising to redefine the therapeutic landscape in the years to come.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.